Integumen plc
("Integumen" or "the Company")
Changes to interests of a significant shareholder
Integumen plc (AIM: SKIN), the speciality pharmaceutical company, has received a notification of a change in the interests of a significant shareholder. In accordance with AIM Rule 17, the following details are now notified:
a) Identity of the significant shareholder: Helium Rising Stars Fund
b) Date of disclosure: 22 January 2019
c) Date of relevant change: 21 January 2019
d) Price, amount and class: 21,240,415 ordinary shares of 0.01p each; price not disclosed
e) Nature of transaction: purchase of shares
f) Nature and extent of significant shareholder's interest: direct and indirect interests
g) Resultant shareholding: 38,962,295 shares, with a direct interest in the shares and an indirect interest in the voting rights, in each case amounting to 8.57%
In compliance with DTR5, a copy of the notification received from this investor is appended.
|
Integumen plc |
Gerard Brandon, CEO
|
+44 (0) 122 392 6660 |
|
SPARK Advisory Partners Limited (Nominated Adviser)
|
Neil Baldwin/Andrew Emmott |
+44 (0) 113 370 8974 |
|
Hybridan LLP (Broker) |
Claire Noyce |
+44 (0) 20 3764 2341 |
About Integumen:
Integumen is a vertically integrated business, collaborating their Labskin technology platform with partners in artificial intelligence, clinical research, medical device and life science. These collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.
The Company combines data analytics with access to therapeutic operational expertise and offers solutions to our clients, from regulatory approvals, right through to marketing fully tested ingredients that have been certified on our Laboratory grown living human tissue.
TR-1: Standard form for notification of major holdings
|
|
||||||
|
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: |
Integumen Plc |
|||||
|
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) |
||||||
|
|
|
|||||
|
2. Reason for the notification (please mark the appropriate box or boxes with an "X") |
||||||
|
An acquisition or disposal of voting rights |
X |
|||||
|
An acquisition or disposal of financial instruments |
|
|||||
|
An event changing the breakdown of voting rights |
X |
|||||
|
Other (please specify)iii: |
|
|||||
|
3. Details of person subject to the notification obligationiv |
||||||
|
Name |
Helium Rising Stars Fund |
|||||
|
City and country of registered office (if applicable) |
Cayman Islands |
|||||
|
4. Full name of shareholder(s) (if different from 3.)v |
||||||
|
Name |
|
|||||
|
City and country of registered office (if applicable) |
|
|||||
|
5. Date on which the threshold was crossed or reachedvi: |
21/01/2019 |
|||||
|
6. Date on which issuer notified (DD/MM/YYYY): |
22/01/2019 |
|||||
|
7. Total positions of person(s) subject to the notification obligation |
||||||
|
|
% of voting rights attached to shares (total of 8. A) |
% of voting rights through financial instruments |
Total of both in % (8.A + 8.B) |
Total number of voting rights of issuervii |
||
|
Resulting situation on the date on which threshold was crossed or reached |
8.57% |
|
8.57% |
454,826,872 |
||
|
Position of previous notification (if applicable) |
4.67% |
|
4.67% |
|
||
|
8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii |
|||||||||
|
A: Voting rights attached to shares |
|||||||||
|
Class/type of ISIN code (if possible) |
Number of voting rightsix |
% of voting rights |
|||||||
|
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) |
Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) |
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) |
Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) |
||||||
|
GB00BYWJ6269 |
38,962,295
|
|
8.57% |
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
SUBTOTAL 8. A |
38,962,295 |
8.57% |
|||||||
|
|
|||||||||
|
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) |
|||||||||
|
Type of financial instrument |
Expiration |
Exercise/ |
Number of voting rights that may be acquired if the instrument is exercised/converted. |
% of voting rights |
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
SUBTOTAL 8. B 1 |
|
|
|||||
|
|
|||||||||
|
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) |
|||||||||
|
Type of financial instrument |
Expiration |
Exercise/ |
Physical or cash settlementxii |
Number of voting rights |
% of voting rights |
||||
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
||||
|
|
|
|
SUBTOTAL 8.B.2 |
|
|
||||
|
|
|||||||||
|
9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") |
||||
|
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii |
|
|||
|
Full chain of controlled undertakings through which the voting rights and/or the |
|
|||
|
Namexv |
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
10. In case of proxy voting, please identify: |
||||
|
Name of the proxy holder |
|
|||
|
The number and % of voting rights held |
|
|||
|
The date until which the voting rights will be held |
|
|||
|
|
||||
|
11. Additional informationxvi |
||||
|
|
||||
|
Place of completion |
Zürich, Switzerland |
|
Date of completion |
22/01/2019 |